Correction: The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients.

Autor: El-Araby RE; Assistant Researcher of Molecular Biology, Central Lab, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Gizah, Egypt. radyeid.elaraby@gmail.com., Khalifa MA; Assistant Prof. of Molecular Biology, Zoology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt., Zoheiry MM; Prof. of Clinical pathology (Immunology), Immunology Research Department, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Gizah, Egypt., Zahran MY; Prof. of Hematology, Clinical Laboratory, Research Department, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Gizah, Egypt., Rady MI; Prof. of Cytochemistry and Histochemistry, Zoology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt., Ibrahim RA; Prof. of Hepatoastroenterology, Hepatoastroenterology Department, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Gizah, Egypt., El-Talkawy MD; Prof. of Hepatoastroenterology, Hepatoastroenterology Department, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Gizah, Egypt., Essawy FM; Prof. of Hematology, Clinical Laboratory, Research Department, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Gizah, Egypt.
Jazyk: angličtina
Zdroj: Cancer gene therapy [Cancer Gene Ther] 2022 Aug; Vol. 29 (8-9), pp. 1297-1298.
DOI: 10.1038/s41417-022-00440-x
Databáze: MEDLINE